We’re going to build Canada’s defence, protect our Arctic, and keep Canada strong.

BCG-unresponsive bladder cancer poses rising costs, limited comparative data, and complex decision-making for the healthcare system. Amanda Myers presents a timely cost-effectiveness analysis of current therapies #EAU25 IBCG Ruchika Talwar Patrick Hensley, MD

Paddington enjoyed riding on Shinkansen (bulletin train) 🚅to Nagoya !

Congrats 👍 #EAU25 Julian Struck Moises Socarras Dr. Christopher Fung Arvin K. George, MD JG Pereira

Top kidney cancer paper of the year at #suo25 - weight loss associated with lower risk of RCC. So happy to see lifestyle getting more attention! Maintaining a healthy body wt ➕ non-smoking, ⬆️ physical activity & 🚫red meat are modifiable ways to reduce RCC risk! #aua25

⭐️ What an innovative use of the 160,000 wrap around LED screens inside Sphere to demonstrate flexible ureteroscopy Amer. Urol. Assn. Steve Nakada Gabriela Gonzalez, MD, MPH Michael Ernst Alison North Ibukunoluwa omole Adam B. Weiner, MD Lindsay Hampson Michelle Van Kuiken, MD Soum Lokeshwar Wai Lee 👇

Facts about Pope Leo XIV >IQ: 145 >Speaks 7 languages >Former professor >Degrees in mathematics & theology >Missionary in Peru for +10 years >First American Pope >Known for humility and intellectual capabilities This isn’t just a Pope This is one of the smartest men alive

⭐️Brilliant tour de force by Dr. Patrizia Giannatempo at #Avenues medical conference in Lisbon 1️⃣New ADCs in development in UC 2️⃣ ctDNA throughout the patient”s MIBC journey may guide personalized treatments. 3️⃣Anti- HER2 ADCs show very promising activity in Urothelial cancers

Diagnostic and therapeutic advances are reshaping how we treat GU cancers — and Dr. Rana McKay, MD, FASCO is at the forefront of the conversation at #ASCO25 A dynamic education session spotlighting evolving paradigms and precision approaches in #GUonc ASCO

⭐️ Great new #ASCO25 stats by OncoAlert and @medicalwatchBC 👉 my.medical.watch/oncoalert/hash… gilberto lopes Emre Yekedüz Dr Joseph McCollom DO Oncology Brothers Bárbara Melão, MD, PhD Dra. María Natalia Gandur Quiroga Jose Fernando Moura, PhD Elisa Agostinetto Petros Grivas Fadi Haddad, MD Luca Arecco, MD Kristina Jankovic, MD Gaia Griguolo Cristiane D Bergerot, PhD, FASCO

⭐️Dr. Alicia Morgans, Dr. Daniel George and IDEOlogy Health hit all the right notes at the #WorldGU25 conference CMA Theater in Nashville! ✨ Cutting-edge panel discussions on kidney, bladder, and prostate cancers ✨ Inspirational talks from cancer patients reminding us why

💡Just released Practice changing study in NEJM👉 Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer. PFS DV vs chemo (median, 13.1 vs. 6.5 months; Overall survival DV vs Chemo (31.5 vs. 16.9 months;) objective response was DV 76.1% (95% CI, 70.3

🙏 Thank you Dr. Brian Rini, Dr. Katy Beckermann , Dr. Petros Grivas, Dr. David Aggen, Dr. Neal Shore, and Dr. Neeraj Agarwal for joining me on OncLive.com Urology Times on Location. Click here 👉 onclive.com/view/rounding-… ❤️ talking about all of the practice changing data GU

👏 Such an inspiring evening celebrating Dr. Stephen Freedland, Dr. Neal Shore, and the EMBARK study investigators ! Click here NEJM just released 👉 nejm.org/doi/full/10.10… Over dinner, we reflected on more than a decade of dedication by the EMBARK study team that led to this

Unforgettable evening at the SMRU-ASRM event in San Antonio, honoring Dr. Peter Schlegel with the Distinguished Service Award and my mentor, Dr. Robert Oates with the prestigious Lifetime Achievement Award. Their groundbreaking contributions to male reproductive medicine will

New study in Urology Gold Journal from Dr. Bradley A. Erickson shows that use of suprapubic tube is a viable long-term solution for select patients with neurogenic bladder. Secondary urologic procedures may be required, and for long-term use, a urologist should place the tube.

🐝 Still buzzing from #ESMO25 💫 Science. Friendship. Purpose. #ESMO25 had it all 🔬✨💪 Appearances by 🎥 G Curigliano MD PhD Sara Tolaney Toni Choueiri, MD Stephen V Liu, MD Narjust Florez, MD, FASCO Dr. Cathy Eng Van Morris, MD Herbert Loong, MBBS, FASCO Vivek Subbiah, MD Petros Grivas Shilpa Gupta Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)

Thanks OncoDaily and 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 for such a fun and meaningful discussion. We discuss ✅need for educational platforms tailored to our reducing attention spans ✅challenges and wins around trials- that make true impact on our patients lives ✅power of network and taking care of

The challenge of getting past Whatiffery applies to the whole clinical journey from referral to ED through to discharge ?